New GSK plant is tonic for troubled pharma sector
Glaxosmithkline (GSK) announced its intention last month to build a £350m manufacturing facility at its plant in Ulverston, Cumbria.
Available to registered users only
Take a Property Week Free trial today
Try Property Week for Free, click below and take two minutes to register with us to gain further access to propertyweek.com (excludes some subscription only content such as financial news and analysis)
Already registered?
If you are registered for newsletters you can already access stories for FREE, enter your details here